🛡️ Aon (AON): The Chairman Just Bought $6.5M. We’re Still Waiting.

A $17B USI Deal, 4.8× Leverage and a Buyback Pause Complicate One of Insurance’s Best Businesses

Lester Knight Is Buying the Dip at $327.48—but FUNanc1al Wants a Bigger Margin of Safety

Aon plc Class A  

NYSE: AON
Price: $323.09
Change: -$3.91 (-1.20%)
As of: September 4, 2026, 4:10 PM ET

⚡ Quick Take / TL;DR

Aon is one of the world's leading risk, insurance, reinsurance and human-capital advisory businesses. Its economics remain impressive: Q2 2026 delivered 5% organic revenue growth, 28.9% adjusted operating margin and 9% adjusted EPS growth, while management reaffirmed its full-year outlook.

Then Aon decided to go elephant hunting.

On August 31, it announced the $17 billion cash acquisition of USI Insurance Services, following its 2024 acquisition of NFP. USI brings approximately $3 billion of revenue and is expected to generate $395 million of annual run-rate net adjusted EBITDA synergies. Management expects the deal to be dilutive to adjusted EPS in 2027 and accretive beginning in 2028.

The catch? Debt.

Aon expects to finance the purchase with new debt, with leverage projected around 4.8× at closing, versus its longer-term 2.8–3.0× objective. Management expects roughly 24 months of deleveraging—and says it does not expect near-term share repurchases while debt repayment takes priority.

And right into that uncertainty stepped Chairman Lester Knight.

With his wallet.

🕵️ Trigger #1: The Chairman Just Bought $6.55 Million

On September 2, Knight purchased 20,000 AON shares for $6,549,688, or approximately $327.48 per share.

It wasn't his first purchase this year.

In February, Knight purchased another 4,000 shares at $319.24, deploying roughly $1.28 million.

That's approximately $7.83 million invested across the two purchases.

And this isn't some newly appointed director trying to look enthusiastic in the annual report.

Knight has chaired Aon's board since 2008. His résumé includes senior roles at Baxter International, CEO and Chairman of Allegiance Corporation, Vice Chairman of Cardinal Health and founding partner of RoundTable Healthcare Partners.

That's a serious signal.

But here's an investing distinction worth remembering:

“An insider buy can tell you when conviction is rising. It cannot tell you when the margin of safety is wide enough.” — FUNanc1al

Knight apparently likes Aon around $327.

We like Aon too.

We'd simply like it cheaper.

🐋 Trigger #2: Wall Street Already Owns the Place

According to the ownership data we reviewed, institutions hold roughly 93.25% of outstanding shares and 94.21% of the float, with major positions held by BlackRock, Vanguard, JPMorgan, Capital World Investors, State Street, Dodge & Cox and others.

Meanwhile, short interest was only about 1.6%, with approximately 2.74 days to cover.

In other words:

The Chairman likes it.

Institutions like it.

The bears apparently have other appointments.

Analysts mostly like it; current analyst tracking also shows a Moderate Buy consensus, although individual ratings and price targets naturally vary and can change quickly. 

All encouraging.

None of it eliminates valuation or balance-sheet risk.

For Aon (AON)'s Institutional Ownership breakdown, 🔍 see here.

💰 Trigger #3: The Business Keeps Performing

Aon's underlying machine remains formidable.

For Q2 2026:

• Revenue reached $4.246 billion, up 2%.
• Organic revenue growth was 5%.
• Adjusted operating income increased 5%.
• Adjusted operating margin expanded 70 basis points to 28.9%.
• Adjusted EPS rose 9% to $3.81.
• First-half free cash flow increased 4% to $846 million.

And before the USI transaction changed the capital-allocation picture, Aon returned $775 million to shareholders during Q2, consisting of $600 million in repurchases and $175 million in dividends.

That last numbers matter.

Because buybacks have been an important component of Aon's shareholder-return machine.

Now they're taking a vacation.

Debt repayment has booked the room.

👉 Want the full picture? Dive into Aon (AON)'s financials here.

🏢 Trigger #4: USI Could Be a Monster Strategic Win

There is plenty to like about the acquisition itself.

USI is the tenth-largest U.S. insurance broker, generating approximately $3 billion in annual revenue with more than 10,500 employees across nearly 200 offices. The acquisition substantially expands Aon's U.S. middle-market reach and its exposure to Excess & Surplus insurance.

Management expects approximately $395 million of annual run-rate net adjusted EBITDA synergies.

The combination also builds on NFP, which Aon acquired in 2024. Management believes the expanded platform can accelerate organic growth while creating greater scale across data, analytics, technology and distribution.

Strategically?

We get it.

Financially?

Now things become much more interesting.

🐘 Trigger #5: Somebody Has to Pay for the Elephant

The USI purchase price is $17 billion, or approximately $16.7 billion net of certain tax attributes.

And Aon intends to finance it with new debt.

Company transaction materials indicate leverage could reach approximately 4.8× at closing, with management targeting a return to 2.8–3.0× in approximately 24 months. Aon reported roughly $15 billion of debt outstanding as of June 30 before the transaction.

There's more.

Aon's presentation estimates approximately:

$160 million of transaction costs.
$550 million of integration costs.
Up to $400 million of retention and performance incentives.

That's potentially more than $1.1 billion around the transaction and integration effort.

Management also expects USI to be dilutive to adjusted EPS in 2027, before becoming accretive in 2028 and thereafter.

That's not a disaster.

It's simply a lot of moving parts.

And giant mergers occasionally develop a strange habit of looking easiest in PowerPoint.

🛑 The Buyback Pause Matters

This may be the most underappreciated part of the thesis.

Aon explicitly says it does not expect to repurchase shares in the near term, prioritizing deleveraging instead.

We actually think that's prudent.

If you've just undertaken a $17 billion debt-funded acquisition, paying down debt instead of aggressively buying stock is hardly evidence that management has lost its mind.

Quite the opposite.

But prudent for the balance sheet doesn't necessarily mean bullish for the stock tomorrow.

Buybacks reduce share count, support EPS growth and return excess capital to owners. Temporarily removing that mechanism means operating growth and successful integration have to carry more of the load.

FUNanc1al Atomic Statement #2:

“A buyback pause can be the right decision for the company and still be the wrong catalyst for the stock.” — FUNanc1al

📊 Trigger #6: Cheaper? Absolutely. Cheap? We're Not Convinced.

Here's where Aon gets particularly tempting.

The valuation has compressed dramatically.

The figures supplied for our analysis show approximately:

Trailing P/E: 18.03×
Forward P/E: 15.29×
Price/Sales: 4.01×
Price/Book: 7.23×
EV/Revenue: 4.78×
EV/EBITDA: 12.47×
5-year expected PEG: 2.46×

Aon's trailing P/E was around 30× a year earlier.

So yes—the stock has become much cheaper relative to itself.

That's different from saying it has become cheap.

A 2.46× PEG, ~4× sales and >7× book valuation accompanying a giant debt-funded acquisition doesn't give us the margin of safety we'd ideally want.

Especially when the next couple of years involve integration, deleveraging and temporarily diminished buybacks.

⚠️ The Risk Ledger

This is ultimately why AON earns 7.15/10 rather than 8+ on our FunStock Index™.

The business is excellent.

The setup isn't.

We see five significant near-term uncertainties: substantially increased leverage; execution risk integrating USI after NFP; no near-term buybacks; USI's expected 2027 EPS dilution; and leadership transition risk around the CFO function.

Add foreign-exchange and interest-rate sensitivity and suddenly the seemingly boring insurance broker has accumulated enough plot twists for a Netflix miniseries.

💡💡💡 Curious about another deep oil exploration play? (joke)
Check our takes on UnitedHealth Group or even Oscar Health.

🎯 FunStock Index™: 7.15 / 10

What we love: enormous insider conviction; defensive and diversified operations; strong institutional sponsorship; very low short interest; consistent organic growth; expanding margins; a substantially compressed earnings multiple; and potentially significant long-term USI strategic value.

What keeps us waiting: leverage, integration complexity, 2027 dilution, buyback suspension, a still-not-obviously-cheap valuation and the simple fact that USI's promised economics haven't been demonstrated yet.

Fred's Take: Great Company. Wrong Price.

Chairman Lester Knight disagrees with us.

That's perfectly fine.

In fact, that's what makes investing interesting.

At approximately $323, we don't think the potential return adequately compensates us for all the things that now have to go right.

Give us another 10–20% discount, however, and the equation gets much more interesting. Roughly speaking, that would put our preferred hunting territory around $260–$290, depending on what happens to earnings, leverage and integration progress in the meantime.

Alternatively, we'd gladly reconsider at a higher price if execution substantially de-risks the story: USI integration progresses smoothly, leverage comes down, cash generation remains strong and management eventually signals that repurchases can resume.

Price isn't the only way a stock becomes cheaper.

Risk reduction can create margin of safety too.

And if AON never reaches our price?

Fine.

There are thousands of stocks.

You don't have to marry every wonderful company you meet.

📌 Signal Extract

“An insider buy can tell you when conviction is rising. It cannot tell you when the margin of safety is wide enough.” — FUNanc1al

🎯 High-Conviction Takeaway

“A buyback pause can be the right decision for the company and still be the wrong catalyst for the stock.” — FUNanc1al

🤔 Food for Thought: The Cross-Hub Connection

There's a broader lesson here that goes well beyond investing.

Good decisions depend on circumstances.

Buying an excellent company can be a bad investment at the wrong price.

Taking on debt can be dangerous—or intelligent if the asset purchased ultimately produces sufficient returns.

Waiting can look passive while actually being an active decision.

And sometimes the hardest thing to do when you really like something is...

nothing.

Patience isn't the absence of action.

Sometimes patience is the action.

Carpe Diem. 🛡️

❓ FAQ

Is Aon stock a buy right now?

We rate AON 7.15/10 on the FunStock Index™. We like the company considerably more than the present risk/reward proposition and would prefer either a larger valuation discount or evidence that USI integration and deleveraging are proceeding successfully.

Why did Chairman Lester Knight buy AON stock?

We cannot know Knight's personal investment rationale unless he states it. What we do know is that he purchased 20,000 shares for approximately $6.55 million on September 2, shortly after the USI transaction announcement. That makes the purchase noteworthy—but not proof that the shares are undervalued.

How large is the USI acquisition?

Aon agreed to acquire USI for $17 billion in cash. USI generates approximately $3 billion of annual revenue, and Aon projects $395 million in annual run-rate net adjusted EBITDA synergies.

When should USI become accretive to Aon earnings?

Aon currently expects the transaction to be dilutive to adjusted EPS in 2027 and accretive beginning in 2028 and thereafter.

Why is Aon pausing share repurchases?

Management intends to prioritize deleveraging following the debt-funded USI acquisition. Aon says it does not expect near-term repurchases while it pays down debt. 

👤 About the Author

Frédéric Marsanne is the founder of FUNanc1al—part market analyst, part storyteller, part accidental comedian. A longtime investor, entrepreneur, and venture-builder across tech, biotech, and fintech, he now blends rigorous financial analysis with a twist of humor to help readers laugh, learn, live healthier lives, and invest a little wiser.

His research focuses on insider buying, hedge funds, valuation, behavioral finance, long-term wealth creation, and the fascinating intersections between business, science, technology, health, passions, and everyday life.

When not decoding SEC filings or poking fun at earnings calls, he's building Cl1Q, writing fiction, painting, creating videos, or discovering new passions to FUNalize.

📝 Editorial Note

Every FUNanc1al article is grounded in human research, analysis, and editorial judgment. Modern AI tools may assist with research organization, editing, and presentation, but every opinion, conclusion, rating, and editorial judgment remains subject to human oversight and responsibility.

To learn more about how we research, write, and review every article, please visit our Editorial Process page.

At FUNanc1al, we focus on high-conviction ideas supported by multiple independent signals—not just headlines.

No single indicator guarantees investment success.

But when insider buying, strong cash generation, institutional sponsorship, the prospect of improving fundamentals, and attractive valuations begin aligning...

we believe those opportunities deserve a closer look.

This analysis combines company disclosures, SEC filings, market data, institutional ownership information, analyst estimates and FUNanc1al's independent interpretation. The USI transaction remains subject to customary closing conditions and regulatory approvals, and projected synergies, leverage reduction, EPS accretion and integration outcomes are forward-looking rather than guaranteed. Aon expects the transaction to close in Q4 2026.

FUNanc1al conclusion: We admire Aon. We respect Lester Knight's multimillion-dollar vote of confidence. We even understand the strategic logic behind USI.

We just don't have to buy it today.

Great company. Wrong price.

For now. 🛡️📊

At FUNanc1al, our objective is not to predict the future with certainty, but to encourage thoughtful analysis, healthy skepticism, long-term thinking, and a smile whenever possible.